Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.
Type
B2c
Founded
2005
Raised
$331.4M
Follow us
Alexa global traffic share
Latest funding Show all
$125,000,000
Post-IPO equity - 2016
Team Size
10+
Employees
$40,000,000 Undisclosed
PE HUB

Aerio Pharmaceuticals takes in about $40 mln

Funding Messaging
$125,000,000 Post-IPO equity
businesswire

Aerie Pharmaceuticals Raises $125 Million in Public Offerings | Business Wire

The Motley Fool

Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today

Stock markets